You are here: Industry Insights > Antibiotic

News List

Sanofi in talks with Evotec to out-licence antibiotic research pharmaphorum
March 12, 2018
Sanofi is in talks with the German biotech Evotec to out-license most of its infectious disease R&D, including novel antimicrobial research.
Nanoparticles as a solution against antibiotic resistance? worldpharmanews
December 18, 2017
Around one in 3,300 children in Germany is born with Mucoviscidosis. A characteristic of this illness is that one channel albumen on the cell surface is disturbed by mutations
FDA launches new tool for sharing information that allows doctors to better manage antibiotic use; i worldpharmanews
December 14, 2017
Today the U.S. Food and Drug Administration is announcing a new approach to get critical updates regarding antibiotics and antifungal drugs to health care professionals as part of an overall effort to combat antimicrobial resistance.
€3.6 million Horizon 2020 Phase II grant secured by Symcel in battle against antibiotic resistance pharmaasia
November 28, 2017
The aim is for multi-resistant bacterial sepsis infections to be validated utilising the sensitive Symcel screening technology.
FDA Berates Lupin for Repeatedly Making Pills That Don't Meet Quality Standards biospace
November 17, 2017
Lupin Ltd., which makes generic antibiotics, antidepressants and heart medications for sale in the U.S., was warned by the Food and Drug Administration for repeatedly ignoring tests showing that pills made at two of its facilities didn’t meet quality stan
Helperby Therapeutics develops sustainable solution for antibiotic resistance biospectrumasia
November 15, 2017
Antibiotic Resistance Breakers is a novel technology that rejuvenates existing antibiotics into long-term effective combination therapies
Alopexx completes first-in-man trial of its novel, broad-spectrum anti-microbial vaccine biospectrumasia
October 27, 2017
Potential to prevent wide range of infections including those caused by antibiotic-resistant organisms.
Defining standards & measures for AMR is the need of the hour biospectrumasia
October 18, 2017
According to one of the report issued by some of the stakeholders last year, antibiotic industry or ingredient manufacturers were responsible for an estimated amount of 30,000-70,000 tons of anti-microbial active waste.
More to be Done by Indian government to cope with rising sale of unapproved antibiotics worldpharmanews
October 11, 2017
In India, the sale of antibiotics requiring the tightest control and regulation is rising the fastest, according to an analysis by researchers at Queen Mary University of London (QMUL) and Newcastle University.
Antibiotic development is inadequate to meet global resistance threat, WHO warns pharmafile
September 21, 2017
WHO has released a report indicating that worldwide development of new antibiotics is not keeping pace with the rising prevalence of antimicrobial resistance, with the risk that we may face an inability to meet growing demand.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page